United States· US:43689-0035_5681a398-bb4e-f076-e063-6294a90ae348
Magnilife Eczema Care
A medicinal product containing sulfur; graphite; daphne mezereum bark; toxicodendron pubescens whole, registered in United States by The Magni Group, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SULFUR; GRAPHITE; DAPHNE MEZEREUM BARK; TOXICODENDRON PUBESCENS WHOLE
- Manufacturer
- The Magni Group, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1143689-0035-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfb932e5-4ac8-4261-a1de-156c1ea35b61 GET /v1/drugs/dfb932e5-4ac8-4261-a1de-156c1ea35b61?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1; 3; 6; 6",
"substance": "SULFUR; GRAPHITE; DAPHNE MEZEREUM BARK; TOXICODENDRON PUBESCENS WHOLE",
"productndc": "43689-0035",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g",
"application_number": "M006",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about sulfur; graphite; daphne mezereum bark; toxicodendron pubescens whole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.